Malaria jab rollout in Cameroon a ‘turning point’, says Gavi chief

Published
0

 Geneva: Chief programme officer of the Gavi Vaccine Alliance, Aurelia Nguyen, stresses a point during an interview.—AFP
Geneva: Chief programme officer of the Gavi Vaccine Alliance, Aurelia Nguyen, stresses a point during an interview.—AFP

GENEVA: The rollout of malaria vaccines in a regular immunisation programme marks a “turning point” in the fight against the disease, Aurelia Nguyen, chief programme officer of the Gavi vaccine alliance, said.

The mosquito-borne disease kills more than 600,000 people a year, mainly in Africa, according to the World Health Organisation. Following a pilot phase, the RTS,S vaccine is being rolled out at scale across the continent — starting in Cameroon on Monday.

Why is the rollout so important?

Nguyen: “It’s a historic day. Up to now we had done a small-scale pilot in three countries — Kenya, Ghana and Malawi — to understand how to use the vaccine. Now in Cameroon we are going straight into routine immunisation.

“This is truly a turning point. We have been working on the malaria vaccine for a very long time. It took 30 years. It is a challenging disease because it is transmitted by a parasite with a very complicated life cycle. “We (now) have a weapon which has proven to be safe and effective.

“There had been a lot of progress in the fight against malaria but we had reached a point where this progress was slowing down. In some countries, cases, hospitalisations and deaths were starting to rise. There are various causes: global warming, population movements.”

Why Cameroon and where next?

Nguyen: “We decided to concentrate first where the need was greatest. Cameroon is one of the countries where disease incidence is fairly high. “So we focused on Cameroon because that’s where the vaccine will really have a positive impact.

“In Cameroon, 30 per cent of consultations are linked to malaria. Having a preventative tool like the vaccine will free up the health system and result in fewer hospitalisations and deaths.

“We are working to start rolling out the vaccine in as many countries as possible. Thirty countries have shown an interest. “We hope to have a fairly broad rollout within the next two years. We are focusing first on the areas most at risk, and then bit by bit we will be able to expand, depending on what the countries want.

Published in Dawn, January 23rd, 2024

Opinion

Editorial

No talks
Updated 17 Oct, 2026

No talks

The government should understand that the PTI’s protest march and its reaction to it will look like nothing more than a storm in a teacup.
Strengthening LGs
17 Oct, 2026

Strengthening LGs

THE ECP has done well to refuse to allow the Punjab administration to push the local government elections to April....
Lesser citizens
17 Oct, 2026

Lesser citizens

FOR decades, discrimination and prejudice have narrowed the space for the country’s minority communities. The HRCP...
Deadly classrooms
Updated 16 Oct, 2026

Deadly classrooms

Parents should not have to become structural engineers to judge whether their children are safe at school.
Diplomatic options
Updated 16 Oct, 2026

Diplomatic options

Regional states know that the alternative to talks — a fully fledged war on both fronts — will bring immeasurable destruction to the Gulf, the Red Sea and the surrounding areas.
Hunger in Pakistan
16 Oct, 2026

Hunger in Pakistan

PAKISTAN’S position as the country most affected by hunger in South Asia is not surprising. An economy battered by...